Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

Overview of attention for article published in Breast Cancer Research and Treatment, June 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 1 policy source

twitter: 9 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 64 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer : Addendum

Cited by National Institute for Health and Care Excellence on 21 Mar 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.